trending Market Intelligence /marketintelligence/en/news-insights/trending/oqKkypEhTkCKkx5Arco6kA2 content esgSubNav
In This List

Cardax plans 200-for-1 reverse stock split

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Cardax plans 200-for-1 reverse stock split

Cardax Inc. said it will effect a 200-for-1 reverse split of its issued and outstanding common stock.

The Honolulu-based biopharmaceutical company said the reverse stock split will be effective at 12:01 a.m. ET on Jan. 15.

The company's common stock will trade on the OTCQB on a split-adjusted basis under its current CDXI ticker symbol.

No fractional shares will be issued under the stock split. Fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.

Cardax develops dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.